La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « Carrier Proteins »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Carotid-Cavernous Sinus Fistula < Carrier Proteins < Case-Control Studies  Facettes :

List of bibliographic references indexed by Carrier Proteins

Number of relevant bibliographic references: 28.
[0-20] [0 - 20][0 - 28][20-27][20-40]
Ident.Authors (with country if any)Title
000017 (2017) Eric M. Merzetti [Canada] ; Lindsay A. Dolomount [Canada] ; Brian E. Staveley [Canada]The FBXO7 homologue nutcracker and binding partner PI31 in Drosophila melanogaster models of Parkinson's disease.
000496 (2015) Jeremy A. Hirota ; Matthew J. Gold ; Paul R. Hiebert ; Leigh G. Parkinson ; Tracee Wee ; Dirk Smith ; Phil M. Hansbro ; Chris Carlsten ; Stephan Vaneeden ; Don D. Sin ; Kelly M. Mcnagny ; Darryl A. KnightThe nucleotide-binding domain, leucine-rich repeat protein 3 inflammasome/IL-1 receptor I axis mediates innate, but not adaptive, immune responses after exposure to particulate matter under 10 μm.
000B61 (2014) Mikko Muona [Finlande] ; Samuel F. Berkovic [Australie] ; Leanne M. Dibbens [Australie] ; Karen L. Oliver [Australie] ; Snezana Maljevic [Allemagne] ; Marta A. Bayly [Australie] ; Tarja Joensuu [Finlande] ; Laura Canafoglia [Italie] ; Silvana Franceschetti [Italie] ; Roberto Michelucci [Italie] ; Salla Markkinen [Finlande] ; Sarah E. Heron [Australie] ; Michael S. Hildebrand [Australie] ; Eva Andermann [Canada] ; Frederick Andermann [Canada] ; Antonio Gambardella [Italie] ; Paolo Tinuper [Italie] ; Laura Licchetta [Italie] ; Ingrid E. Scheffer [Australie] ; Chiara Criscuolo [Italie] ; Alessandro Filla [Italie] ; Edoardo Ferlazzo [Italie] ; Jamil Ahmad [Pakistan] ; Adeel Ahmad [Pakistan] ; Betul Baykan [Turquie] ; Edith Said [Malte] ; Meral Topcu [Turquie] ; Patrizia Riguzzi [Italie] ; Mary D. King [Irlande (pays)] ; Cigdem Ozkara [Turquie] ; Danielle M. Andrade [Canada] ; Bernt A. Engelsen [Norvège] ; Arielle Crespel [France] ; Matthias Lindenau [Allemagne] ; Ebba Lohmann [Allemagne] ; Veronica Saletti [Italie] ; João Massano [Portugal] ; Michael Privitera [États-Unis] ; Alberto J. Espay [États-Unis] ; Birgit Kauffmann [Allemagne] ; Michael Duchowny [États-Unis] ; Rikke S. M Ller [Danemark] ; Rachel Straussberg [Israël] ; Zaid Afawi [Israël] ; Bruria Ben-Zeev [Israël] ; Kaitlin E. Samocha [États-Unis] ; Mark J. Daly [États-Unis] ; Steven Petrou [Australie] ; Holger Lerche [Allemagne] ; Aarno Palotie [Finlande, États-Unis, Royaume-Uni] ; Anna-Elina Lehesjoki [Finlande]A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy
001113 (2012) Denisa Urban [Canada] ; Ling Li ; Hilary Christensen ; Fred G. Pluthero ; Shao Zun Chen ; Michael Puhacz ; Parvesh M. Garg ; Kiran K. Lanka ; James J. Cummings ; Helmut Kramer ; James D. Wasmuth ; John Parkinson ; Walter H A. KahrThe VPS33B-binding protein VPS16B is required in megakaryocyte and platelet α-granule biogenesis.
002B96 (2004) Suneil K. Kalia [Canada] ; Sang Lee ; Patrice D. Smith ; Li Liu ; Stephen J. Crocker ; Thorhildur E. Thorarinsdottir ; John R. Glover ; Edward A. Fon ; David S. Park ; Andres M. LozanoBAG5 inhibits parkin and enhances dopaminergic neuron degeneration.
003112 (2001) C J Sinclair [Canada] ; A E Powell ; W. Xiong ; C G Larivière ; S A Baldwin ; C E Cass ; J D Young ; F E ParkinsonNucleoside transporter subtype expression: effects on potency of adenosine kinase inhibitors.
003265 (2001) Christopher J. D. Sinclair [Canada] ; Ljiljana Krizanac-Bengez [États-Unis] ; Kathë A. Stanness [États-Unis] ; Damir Janigro [États-Unis] ; Fiona E. Parkinson [Canada]Adenosine permeation of a dynamic in vitro blood–brain barrier inhibited by dipyridamole
003308 (2001) M. Guttman [Canada] ; D. Stewart [Canada] ; D. Hussey [Canada] ; A. Wilson [Canada] ; S. Houle [Canada] ; S. Kish [Canada]Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD
003362 (2000) C J Sinclair [Canada] ; C G Larivière ; J D Young ; C E Cass ; S A Baldwin ; F E ParkinsonPurine uptake and release in rat C6 glioma cells: nucleoside transport and purine metabolism under ATP-depleting conditions.
003363 (2000) Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
003383 (2000) Christopher J. D Sinclair [Canada] ; P. Nicholas Shepel [Canada] ; Jonathan D. Geiger [Canada] ; Fiona E. Parkinson [Canada]Stimulation of nucleoside efflux and inhibition of adenosine kinase by A1 adenosine receptor activation
003440 (2000) Sophie Callier [Canada, France] ; Marc Morissette [Canada] ; Michelle Grbois [Canada] ; Thérèse Di Paolo [Canada]Stereospecific prevention by 17β‐estradiol of MPTP‐induced dopamine depletion in mice
003485 (2000) Chong S. Lee [Canada] ; Ali Samii [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Michael Schulzer [Canada] ; James E. Holden [États-Unis] ; Jess Wudel [Canada] ; Pramod K. Pal [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease
003513 (2000) J. M. Van Kampen [Canada] ; E. G. Mcgeer [Canada] ; A. Jon Stoessl [Canada]Dopamine transporter function assessed by antisense knockdown in the rat: Protection from dopamine neurotoxicity
003618 (1999) D C Vines [Canada] ; B D Ivo ; J R Ballinger ; M. IchiseExternal radioactive reference markers in SPECT imaging of the dopamine system.
003620 (1999) C M Anderson [Canada] ; W. Xiong ; J D Geiger ; J D Young ; C E Cass ; S A Baldwin ; F E ParkinsonDistribution of equilibrative, nitrobenzylthioinosine-sensitive nucleoside transporters (ENT1) in brain.
003673 (1999) Christopher M. Anderson [Canada, États-Unis] ; Stephen A. Baldwin [Royaume-Uni] ; James D. Young [Canada] ; Carol E. Cass [Canada] ; Fiona E. Parkinson [Canada]Distribution of mRNA encoding a nitrobenzylthioinosine-insensitive nucleoside transporter (ENT2) in rat brain
003800 (1999) M. Ichise [Canada] ; Y. J. Kim [Canada] ; J. R. Ballinger [Canada] ; D. Vines [Canada] ; S. S. Erami [Canada] ; F. Tanaka [Canada] ; A. E. Lang [Canada]SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD
003822 (1999) M. Ichise [Canada] ; Y. J. Kim ; S. S. Erami ; J. R. Ballinger ; D. Vines ; F. Tanaka ; A. E. LangFunctional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-β-CIT SPECT data
003A60 (1997) M. Guttman [Canada] ; J. Burkholder ; S J Kish ; D. Hussey ; A. Wilson ; J. Dasilva ; S. Houle[11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: implications for the symptomatic threshold.
003A62 (1997) S L Borgland [Canada] ; F E ParkinsonUptake and release of [3H]formycin B via sodium-dependent nucleoside transporters in mouse leukemic L1210/MA27.1 cells.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Carrier Proteins" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Carrier Proteins" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Carrier Proteins
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022